Silica as an Anti-Caking Agent: Mechanism, Dosage and Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Mesoporous Silica? Structure, Pore Size and Applications in Drug Delivery and Catalysis
  • Keywords: silica in cosmetics
  • Published: 2026-11-20 06:57:49
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Fang, W., Yang, J., Gong, J. & Zheng, N. Photo‐and pH‐triggered release of anticancer drugs from mesoporous silica‐coated Pd@Ag nanoparticles. Adv. Funct. Mater. 22, 842-848 (2012). Post CAS Google Scholar

Silica as a Rheology Modifier: How It Controls Viscosity and Flow

Cab-O-Sil M-5: Specifications, Uses and Equivalent Fumed Silica Grades
Desai, P. P., Date, A. A. & Patravale, V. B. Overcoming poor oral bioavailability utilizing nanoparticle formulations-opportunities and limitations. Drug Discov. Today Technol. 9, e87-e95 (2012). Post CAS Google Scholar
What Is Colloidal Silica? Properties, Types and Uses in Polishing, Coatings and Binders
Li, Y. et al. Protein shell-encapsulated Pt clusters as continuous O 2 -supplied biocoats for photodynamic therapy in hypoxic cancer cells. ACS Appl. Mater. Interfac. 11, 17215-17225 (2019). Article CAS Google Scholar
Feed Grade Silica: Specifications and Uses as a Carrier and Flow Agent in Animal Feed
Spherical Silica Manufacturer: Key Capabilities, Purity Control and Selection Criteria
Secondly, it is needed to construct simple but efficient MSNs-based nanoplatforms. The abundant traits of MSNs have led to their vast exploitation as multifunctional nanocarriers, and this may be accompanied by the introduction of two or more elements into MSNs. Although these multifunctional nanoplatforms have proven to be really effective in numerous papers, the complexity of these platforms does not appear to be friendly to the scale-up preparation and clinical translation. On the one hand, it is well known that the laboratory-level synthesis methods of MSN are very different from those used for industrial scale-up production required for clinical screening and use. The reproducibility and batch stability of nanoformulations are always an important component to consider in industrial scale-up production, and in this process, simplifying the production steps is the key to promote the industrial scale-up production. Nonetheless, the complex MSNs-based nanoplatforms call for higher nanoformulation preparation technologies and more stringent storage methods, which often call for more time, effort, and economic investments. On the other hand, the multiple components may introduce more unsafe factors, it appears to be an enormous challenge at this stage to systematically reveal the toxicity mechanisms of these different components when we still do not entirely understand the toxicity mechanisms of MSNs. Hence, it is advocated to slim down the MSNs-based platform as much as possible while meeting the clinical requirements.

Silica for Rheology Control: How to Select the Right Silica and Dosage

What is silica (SiO₂)?

silica for feed carrier Park, J. H., Dumani, D. S., Arsiwala, A., Emelianov, S. & Kane, R. S. Tunable aggregation of gold-silica janus nanoparticles to enable contrast-enhanced multiwavelength photoacoustic imaging in vivo. Nanoscale 10, 15365-15370 (2018). Article CAS PubMed Google Scholar

What is the difference between fumed silica and precipitated silica?

silica refractive index

What drives silica raw material prices?

foundry silica sand MSNs are gradually being developed as promising drug delivery carriers due to their brilliant biocompatibility, biodegradability, and greatly ordered pore structure. Owing to the great flexibility in tuning the surface properties of MSNs, specific surface functionalization modification of MSNs can achieve precise modulation of drug delivery behavior, thus to meet the application requirements. Currently, the most researched is the construction of stimuli-responsive MSNs-based drug delivery system (Fig. 6c ), i.e., when MSNs reach the lesion site, the release of drugs is controllably stimulated by specific internal or external components, thus achieving the improved drug utilization and staying away from drug leakage at non-lesion sites. 259, 272, 331 The most core step in this process is connecting some caps with stimulus-responsive properties onto the MSNs surface, which can be called gatekeepers, 119, 158 nanovalves, 332, 333 or others. Once the therapeutic drug is filled into the mesopore of MSNs, the pore entrances are blocked by the caps to prevent the drug from diffusing out. Under normal physiological conditions, the caps always keep the pores in a closed state, but when reaching to the lesion, the caps are separated under the stimulation of certain components, which in turn induces targeted on-demand release of drugs. These caps can be polymers, 334 metal/metal compound NPs, 170, 335 biomolecules, 336 etc. While exogenous stimuli such as light, ultrasound, magnetic field and electric field, endogenous stimuli such as temperature, pH, redox agents, and enzymes, can activate the caps. Several examples about the surface modification of MSNs and the corresponding stimuli-responsive plans are briefly clarified here.

Cite this article: Silica Raw Materials News. "Silica for Beer Clarification: How Silica Gel Improves Beer Stability ." Published 2026-11-20 06:57:49. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.